Real body recomposition is rarely a single-pathway problem. Fat metabolism is governed by one set of signals, muscle growth runs on another, and recovery sits on yet another, which is why elite protocols rarely lean on one intervention. The Tesamorelin, MGF, and Ipamorelin stack pairs three peptides that act through distinct but complementary mechanisms: Tesamorelin and Ipamorelin prompt the pituitary to release the body's own growth hormone, while MGF works locally in muscle tissue after training. At AgeRejuvenation, this protocol is offered under provider supervision and built from your labs, not dispensed from a menu, with benefits framed as what the peptides may support rather than guaranteed outcomes.
At AgeRejuvenation, the Tesamorelin, MGF, and Ipamorelin stack is built from your labs and overseen by a physician, not dispensed by questionnaire. We start with comprehensive testing and a goals review, decide whether this triple-peptide protocol fits your biology, and monitor your response over a defined cycle. This guide explains what the stack is, how each peptide works, what it may support, who is a candidate, how it is administered, the side effects and safety considerations, what to expect, and how it compares with single-peptide approaches.
What Is the Tesamorelin, MGF, and Ipamorelin Stack?
Answer: The Tesamorelin, MGF, and Ipamorelin stack combines three peptides that target body recomposition through distinct but complementary mechanisms, covering fat metabolism, systemic growth hormone signaling, and local muscle repair within a single supervised protocol.
Peptides are short chains of amino acids that act as signaling molecules in the body, as the National Library of Medicine explains in its overview of how proteins and peptides function. Each peptide in this stack carries a different message. Tesamorelin and Ipamorelin are growth hormone secretagogues, meaning they prompt your own pituitary to release growth hormone, while MGF (Mechano Growth Factor) acts locally inside muscle tissue after exercise. Rather than relying on one pathway, the stack is designed to engage all three at once, which is why it is positioned as a precision protocol rather than a single product.
How Does Each Peptide in the Stack Work?
Answer: Tesamorelin stimulates pituitary growth hormone release and has been studied for reducing visceral fat, Ipamorelin produces selective growth hormone pulses through the ghrelin receptor pathway, and MGF activates muscle satellite cells locally to support repair after training.
Tesamorelin is a synthetic analog of growth hormone-releasing hormone (GHRH); the U.S. Food and Drug Administration has approved tesamorelin for the reduction of excess abdominal fat in adults with HIV-associated lipodystrophy, and that visceral-fat mechanism is part of why it appears in body-composition protocols. Ipamorelin is valued for its selectivity, producing growth hormone pulses without the cortisol or prolactin elevation seen with some older secretagogues. MGF is a splice variant of IGF-1 generated in muscle in response to mechanical load, and it is studied for its role in activating the satellite cells involved in muscle fiber repair. Together they aim to cover fat metabolism, systemic signaling, and direct tissue repair.
Why Does Body Composition Get Harder With Age?
Answer: Growth hormone and IGF-1 output decline with age, deep-sleep windows that trigger natural growth hormone pulses shorten, and these shifts make fat harder to lose and muscle harder to keep, which is the gap this stack is designed to address.
By the time many adults reach midlife, the same pattern shows up: workouts that once produced results deliver less, abdominal fat resists diet and cardio, and recovery from training stretches from hours into days. This is endocrinology, not effort. Growth hormone production peaks in adolescence and declines through adulthood, and IGF-1, the downstream messenger that drives muscle protein synthesis and tissue repair, declines along with it. The Cleveland Clinic notes that growth hormone supports muscle, bone, and metabolism and that levels fall over time. The stack is built to support the signaling that naturally tapers, rather than to override it.
What May This Stack Help Support?
Answer: The stack may support reduction of stubborn visceral fat, renewed muscle adaptation in trained adults who have plateaued, faster recovery between sessions, and the restoration of growth hormone signaling that declines with age, with results varying by individual.
These are framed as goals patients pursue, not promises. Stubborn visceral fat is one focus area, since Tesamorelin is specifically studied for reducing deep abdominal fat that wraps around organs and resists caloric restriction. Patients who train consistently but have stopped seeing adaptation may use the stack to re-engage hypertrophy and repair signaling, with MGF targeting the satellite-cell activation required for new muscle growth. Slow recovery is another, since Ipamorelin's effect on growth hormone pulse patterns during deep sleep may shorten the window between hard sessions. Outcomes depend on your biology, your training, and your protocol.
Who Is a Candidate for This Peptide Stack?
Answer: Good candidates are generally adults experiencing age-related declines in body composition or recovery who clear a provider evaluation, lab review, and medication check first; it is not a beginner protocol or a substitute for foundational training and nutrition.
This stack is designed for specific presentations that simpler interventions have not resolved, typically adults in their 40s, 50s, and 60s feeling the metabolic and structural effects of declining growth hormone. Candidacy depends on your health history, current medications, hormone labs, and goals. People who are pregnant or breastfeeding, or who are managing active cancer or other serious conditions, should not start these peptides without specialist guidance. A provider weighs your individual picture before any protocol begins.
How Is the Stack Administered?
Answer: The peptides are given as small subcutaneous injections, often self-administered around training, with Tesamorelin and Ipamorelin timed to support natural growth hormone release and MGF timed to the post-exercise window when muscle repair signaling is most active.
Subcutaneous injection means the dose is delivered just under the skin with a fine needle, a route commonly used for peptide protocols because it allows steady, self-managed dosing. Your provider sets timing, dose ranges, and cycle length based on your labs and response rather than a fixed template, and adjusts over the protocol. Many patients find self-injection straightforward after instruction, and the plan is reviewed at follow-up so the schedule fits both your physiology and your daily routine.
What Are the Side Effects and Safety Considerations?
Answer: Most reported side effects are mild and dose-related, including injection-site reactions, transient water retention, and occasional numbness or tingling; growth hormone secretagogues should be used only under medical supervision with appropriate lab monitoring.
Because these peptides influence growth hormone and IGF-1 signaling, monitoring matters. Providers commonly track IGF-1 and metabolic markers during a protocol and adjust dosing to keep it within an appropriate range. It is also worth noting the regulatory context honestly: many peptides used in performance protocols are not FDA-approved for body composition, and Tesamorelin's approval is specific to HIV-associated lipodystrophy. That is exactly why our providers review your complete medication list, supervise dosing, and monitor your response rather than dispensing and walking away.
What Should I Expect From Treatment at AgeRejuvenation?
Answer: Expect a comprehensive lab evaluation, a goals and medication review, a personalized protocol if the stack is appropriate, and ongoing monitoring with dose adjustments based on your response, all coordinated within our supervised peptide program.
Every protocol here begins with comprehensive labs: hormone panels, IGF-1 levels, metabolic markers, and body composition analysis, so doses are built on your actual biology. Most patients run an initial protocol of three to six months before reassessment. Throughout, providers track IGF-1, metabolic markers, and how you feel and perform, adjusting as needed. This integration with the rest of your health plan is what separates a supervised protocol from a set-and-forget prescription.
How Does the Stack Compare to a Single Peptide?
Answer: A single growth hormone secretagogue addresses one pathway, while this stack is designed to cover three at once, pairing systemic growth hormone signaling from Tesamorelin and Ipamorelin with the local muscle-repair signaling of MGF.
| Approach | Primary mechanism | What it targets | Often suits |
|---|---|---|---|
| Tesamorelin alone | GHRH analog stimulating growth hormone release | Visceral fat reduction | Patients focused mainly on abdominal fat |
| Ipamorelin alone | Selective growth hormone pulse via ghrelin receptor | General growth hormone support, recovery | Patients wanting a clean, single secretagogue |
| MGF alone | Local IGF-1 splice variant in muscle | Post-training muscle repair | Patients focused mainly on muscle adaptation |
| The three-peptide stack | All three mechanisms combined | Fat metabolism, growth hormone signaling, and muscle repair | Adults with multiple plateaus who clear evaluation |
The advantage of the combination is biological coverage that no single peptide provides alone, but it also asks for more clinical oversight. The right approach is the one matched to your labs and goals, and it can change over time as you respond.
Why Choose AgeRejuvenation for This Stack?
Answer: AgeRejuvenation builds this protocol from comprehensive labs under physician oversight, with honest framing of the evidence and dose adjustments based on your response, rather than dispensing a fixed prescription from a menu.
A protocol using three synergistic peptides rewards providers who understand how each component interacts with the others and with your existing hormonal and metabolic picture. Care is overseen by Chief Medical Director Dr. Dawn Ericsson, MD, alongside a team that includes nurse practitioners and patient care advisors. We dose from your panel, monitor IGF-1 and metabolic markers, and explain what your protocol is doing and why, so you are a partner in your care. This stack is one part of our supervised peptide therapy program, which is designed around your labs and your goals rather than a one-size-fits-all template.
Explore more in our wellness center services .
